3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
3LQ8_88Z_P90584.pdb,88Z,3LQ8,P90584,280,324,97,0.652,0.346,Selleck,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,Phase 2,VEGFR inhibitor,Uniprot,42642645,A,MO15-related protein kinase Pfmrk [Plasmodium falciparum],229,-8.645
3LQ8_88Z_P62343.pdb,88Z,3LQ8,P62343,280,524,66,0.702,0.236,Selleck,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,Phase 2,VEGFR inhibitor,Uniprot,42642645,A,protein kinase [Plasmodium falciparum],174,-8.811
